Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02634658 · ClinicalTrials.gov registry record · NA

The Diagnosis and Incidence of Critical Illness Polyneuromyopathy in Medical and Neurosurgical ICU Patients

A NA study of Critical Illness, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT02634658: Completed NA study of Critical Illness, sponsored by University of Colorado, Denver.

NCT02634658 is a NA study of Critical Illness that has completed, run by University of Colorado, Denver. The registered enrollment target is 120 participants, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02634658, a NA study of Critical Illness, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This study plans to learn more about whether simpler diagnostic tests can be used to identify the development of acute neuromuscular loss of function in patients with critical illness and respiratory failure receiving mechanical ventilation. ICU patients admitted to the University of Colorado Hospital will be screened for eligibility and enrollment in the study to receive weekly measurements of nerve and muscle function through nerve conduction studies (NCS), muscle ultrasound tests, and concentric needle electromyography (EMG) tests.

Primary Outcome

Subjects have CIPNM if either Moss/Quan criteria for (CIP) or (CIM) criteria are met: CIP: SNAP amplitudes \< 80% of lower norm limit of 2+ nerves, Reduced recruitment on EMG, Absence of decremental response, and MRC score \< 48 or clinical weakness on exam CIM: SNAP amplitudes \> 80% of the lower norm limit of 2+ nerves, CMAP amplitudes \< 80% of the lower limit of normal in two or more nerves without conduction block, needle EMG with short-duration, low amplitude motor unit potentials with

Conditions Studied

Interventions

  • OTHER Electromyography
  • OTHER Muscle Ultrasound
  • OTHER Nerve Conduction Study

Study Locations (1)

Colorado

  • University of Colorado Hospital - Aurora

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2009-06
Est. Completion 2015-09
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT02634658 record still lists

NCT02634658 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 3 interventions - of which Electromyography is the first listed.

NCT02634658 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT02634658 about?

NCT02634658 is a clinical study titled "The Diagnosis and Incidence of Critical Illness Polyneuromyopathy in Medical and Neurosurgical ICU Patients". This study plans to learn more about whether simpler diagnostic tests can be used to identify the development of acute neuromuscular loss of function in patients with critical illness and respiratory failure receiving mechanical ventilation. ICU patients admitted to the University of Colorado Hospit...

What is the current status of trial NCT02634658?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2009-06. Estimated completion is 2015-09.

What conditions does trial NCT02634658 study?

This clinical trial studies the following conditions: Critical Illness.

What interventions are being tested in trial NCT02634658?

The interventions under investigation include: Electromyography (OTHER), Muscle Ultrasound (OTHER), Nerve Conduction Study (OTHER).

Who is sponsoring clinical trial NCT02634658?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02634658 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02634658's enrollment target sits among peer trials

120 58th of 91 higher than 33 of 91 other Critical Illness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02634658, the US trial registry maintained by the National Library of Medicine. NCT02634658 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.